Cargando…

Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study

OBJECTIVE: To evaluate the diagnostic performance of donor-derived plasma cell-free DNA (cfDNA) in discriminating antibody-mediated rejection (ABMR) or de novo donor-specific antibodies (DSA) without histological lesions in kidney allograft recipients. METHODS: In this prospective single center obse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huanxi, Zheng, Chunting, Li, Xirui, Fu, Qian, Li, Jun, Su, Qun, Zeng, Liuhong, Liu, Zu, Wang, Jiali, Huang, Huiting, Xu, Bowen, Ye, Mingzhi, Liu, Longshan, Wang, Changxi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058974/ https://www.ncbi.nlm.nih.gov/pubmed/32184785 http://dx.doi.org/10.3389/fimmu.2020.00342

Ejemplares similares

Plasma Soluble CD146 as a Potential Diagnostic Marker of Acute Rejection in Kidney Transplantation
por: Liao, Jun, et al.
Publicado: (2020)

Dynamics of Donor-Derived Cell-Free DNA at the Early Phase After Pediatric Kidney Transplantation: A Prospective Cohort Study
por: Nie, Weijian, et al.
Publicado: (2022)

Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study
por: Wei, Yongcheng, et al.
Publicado: (2021)

Serum Soluble B Cell-Activating Factor Is a Non-Invasive Biomarker of Antibody-Mediated Rejection in Kidney Allograft With Satisfactory Risk Stratification Performance But Negligible Diagnostic Value
por: Wu, Shenghui, et al.
Publicado: (2022)

Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1
por: Li, Xirui, et al.
Publicado: (2020)

Eplet-Predicted Antigens: An Attempt to Introduce Eplets into Unacceptable Antigen Determination and Calculated Panel-Reactive Antibody Calculation Facilitating Kidney Allocation
por: Wu, Wenrui, et al.
Publicado: (2022)

Successful single kidney transplantation from pediatric donors less than or equal to 10 kg to adult recipient: a retrospective cohort study
por: Chen, Chuxiao, et al.
Publicado: (2021)

Single kidney transplantation from pediatric deceased donors in China: the outcomes and risk factors of graft survival
por: Huang, Mingchuan, et al.
Publicado: (2022)

Ginkgo biloba extract EGb761 attenuates brain death-induced renal injury by inhibiting pro-inflammatory cytokines and the SAPK and JAK-STAT signalings
por: Li, Yifu, et al.
Publicado: (2017)

Interferon-gamma FlowSpot assay for the measurement of the T-cell response to cytomegalovirus
por: Ye, Qianyu, et al.
Publicado: (2023)

Application of plasma donor-derived cell free DNA for lung allograft rejection diagnosis in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2023)

Transplantation of a single kidney from pediatric donors less than 10 kg to children with poor access to transplantation: a two-year outcome analysis
por: Su, Xiaojun, et al.
Publicado: (2020)

Steroid Avoidance or Withdrawal Regimens in Paediatric Kidney Transplantation: A Meta-Analysis of Randomised Controlled Trials
por: Zhang, Huanxi, et al.
Publicado: (2016)

Endothelial failure and rejection in recipients of corneas from the same donor
por: Downward, Lewis, et al.
Publicado: (2022)

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients
por: Jordan, Stanley C., et al.
Publicado: (2018)

Repeat kidney transplant recipients with active rejection have elevated donor‐derived cell‐free DNA
por: Mehta, Shikha G., et al.
Publicado: (2018)

Preliminary clinical experience applying donor-derived cell-free DNA to discern rejection in pediatric liver transplant recipients
por: Zhao, Dong, et al.
Publicado: (2021)

Comparison of efficacy and safety between febuxostat and allopurinol in early post‐renal transplant recipients with new onset of hyperuricemia
por: Shen, Xiaoju, et al.
Publicado: (2018)

Risk factors and outcomes of prolonged recovery from delayed graft function after deceased kidney transplantation
por: Zhang, Huanxi, et al.
Publicado: (2020)

THE EFFECT OF SKIN HOMOGRAFT REJECTION ON RECIPIENT AND DONOR MIXED LEUKOCYTE CULTURES
por: Oppenheim, Joost J., et al.
Publicado: (1965)

Abdominal catheter-induced intussusception following renal transplantation in two pediatric recipients: 2 cases report and literature review
por: Gao, Pengfei, et al.
Publicado: (2023)

Careful clinical evaluation of donor fraction cell-free DNA in rejection surveillance after heart transplantation
por: Napoli, Claudio, et al.
Publicado: (2020)

Diagnostic value of donor‐derived cell‐free DNA to predict antibody‐mediated rejection in donor‐specific antibody‐positive renal allograft recipients
por: Mayer, Katharina A., et al.
Publicado: (2021)

Engineered Small Extracellular Vesicles as a FGL1/PD‐L1 Dual‐Targeting Delivery System for Alleviating Immune Rejection
por: Tsai, Hsiang‐i, et al.
Publicado: (2021)

Observed elevated donor‐derived cell free DNA in orthotopic heart transplant recipients without clinical evidence of rejection
por: Afzal, Aasim, et al.
Publicado: (2021)

Donor plasma mitochondrial DNA is associated with antibody-mediated rejection in renal allograft recipients
por: Han, Fei, et al.
Publicado: (2021)

Incidence, clinical features and risk factors of tacrolimus induced idiosyncratic liver injury in renal transplant recipients: A nested case-control study
por: Lv, Binbin, et al.
Publicado: (2023)

Combining Clinical Parameters and Acute Tubular Injury Grading Is Superior in Predicting the Prognosis of Deceased-Donor Kidney Transplantation: A 7-Year Observational Study
por: Wang, Jiali, et al.
Publicado: (2022)

Genotype and phenotype analysis and transplantation strategy in children with kidney failure caused by NPHP
por: Li, Jianyi, et al.
Publicado: (2022)

Donor-But Not Recipient-Derived Cells Produce Collagen-1 in Chronically Rejected Cardiac Allografts
por: Balam, Saidou, et al.
Publicado: (2022)

The Measurement of Donor-Specific Cell-Free DNA Identifies Recipients With Biopsy-Proven Acute Rejection Requiring Treatment After Liver Transplantation
por: Goh, Su Kah, et al.
Publicado: (2019)

Evaluation of predictive models for delayed graft function of deceased kidney transplantation
por: Zhang, Huanxi, et al.
Publicado: (2017)

Detection of Donor-Derived Microparticles in the Peripheral Blood of a Hand Transplant Recipient During Rejection
por: Kim, Joseph Y., et al.
Publicado: (2017)

Donor-Derived Cell-Free DNA and Active Rejection in Renal Allografts
por: Fernando, Edwin, et al.
Publicado: (2023)

Combining Donor-derived Cell-free DNA Fraction and Quantity to Detect Kidney Transplant Rejection Using Molecular Diagnoses and Histology as Confirmation
por: Halloran, Philip F., et al.
Publicado: (2022)

Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection
Publicado: (1992)

Donor and recipient genetic variants in NLRP3 associate with early acute rejection following kidney transplantation
por: Dessing, Mark C., et al.
Publicado: (2016)

Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
por: Li, Yunhui, et al.
Publicado: (2023)

Induction therapy with thymoglobulin or interleukin-2 receptor antagonist for Chinese recipients of living donor renal transplantation: a retrospective study
por: Qiu, Jiang, et al.
Publicado: (2019)

Deep sequencing of DNA from urine of kidney allograft recipients to estimate donor/recipient-specific DNA fractions
por: Belkadi, Aziz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4naums7jm9fsr7d15f29cpv5rs